Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Proleukin
Active Ingredient: Aldesleukin 18MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharmaceuticals UK Limited, West Sussex, United Kingdom
Bayer HealthCare Pharmaceuticals Inc, Emeryville, United States of America
Note: This renewed consent is valid for two years from 27 January 2013.
Dated this 12th day of December 2012.
DR STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).